VLDLR and atherosclerosis: An interesting study demonstrated the ability of a peptide sequence—CTHRSSVVC (PepA), which mimics the CD163 molecule tripeptide “RSS” motif (Etzerodt et al., 2014) to bind inflammatory foci present in atheroma plaques in carotid biopsies of human patients, spleen tissues, and a low-density lipoprotein receptor knockout (LDLr−/−) mouse model of atherosclerosis (Silva et al., 2016).